Stock Information
First Tracks Biotherapeutics Inc (TRAX)
Ticker Symbol: TRAX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,188.09 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): N/A
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: N/A%
Latest News
-
First Tracks: ANB033 Delivers, But Cohort 2 Must Follow Through
Tue, Oct 13, 2026 7:15 AM
-
First Tracks climbs on ‘impressive’ celiac study data
Mon, Oct 12, 2026 9:26 PM
-
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged
Mon, Oct 12, 2026 8:10 PM
-
First Tracks’ ANB033 Clears Key Phase Ib Celiac Disease Study Goals
Mon, Oct 12, 2026 5:02 PM
-
These stocks are gapping in today's session
Mon, Oct 12, 2026 2:30 PM
-
First Tracks Biotherapeutics Shares Jump 20% After Positive Phase 1b Celiac Disease Trial Results
Mon, Oct 12, 2026 12:44 PM
-
These stocks are moving in today's pre-market session
Mon, Oct 12, 2026 12:30 PM
-
Why Is First Tracks Biotherapeutics Stock Soaring Monday?
Mon, Oct 12, 2026 12:23 PM
-
Dow Gains Over 200 Points; Chipotle Shares Move Lower
Mon, Oct 12, 2026 12:05 PM
-
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease
Mon, Oct 12, 2026 11:00 AM
Key Financials
Financial data not available
